Trials / Completed
CompletedNCT04417647
G-Wound (VZ for Wound Treatment)
A Prospective, Randomized, Open-label, Controlled, Exploratory Trial to Investigate the Safety and Tolerability of Topically Administered VZ in Healthy Male Subjects With Artificial Dermal Wounds
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Glock Health, Science and Research GmbH · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective, randomized, open-label, controlled, exploratory trial that aims to investigate the local skin tolerability of topically administered VZ and to evaluate efficacy and safety parameters associated with improved wound condition and healing
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VZ powder (purified clinoptilolite) | VZ powder will be applied topically to the open surface of the verum treatment-assigned wound to cover the entire wound area. Following each VZ application, wounds will be protected by wound dressing (non-adhesive wound dressing (AdapticTM) and conventional protective Mepore® dressing). |
| PROCEDURE | Standard of care (SoC) | wound cleansing (0.9% saline solution) and wound dressing (non-adhesive wound dressing (AdapticTM) and conventional protective Mepore® dressing) will be applied to the SoC-assigned wound. |
Timeline
- Start date
- 2020-06-05
- Primary completion
- 2020-07-31
- Completion
- 2020-08-13
- First posted
- 2020-06-05
- Last updated
- 2020-11-13
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04417647. Inclusion in this directory is not an endorsement.